THBS1 and neoplasm: A significant increase in both TSP-1 and VEGF expression was found in the metronomic CPT-11-treated tumours (1.95±0.05 and 1.62±0.04 vs 1.0 of control expression; P<0.05) whereas no significant changes were demonstrated at the MTD dose (Figure 7B).